Trial design for evaluating novel treatments during an outbreak of an infectious disease

Whitehead, J. R., Olliaro, P., Lang, T. & Horby, P. W., 02/2016, In: Clinical Trials. 13, 1, p. 31-38 8 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol

Arabi, Y., Balkhy, H., Hajeer, A. H., Bouchama, A., Hayden, F. G., Al-Omari, A., Al-Hameed, F. M., Taha, Y., Shindo, N., Whitehead, J. R., Merson, L., AlJohani, S., Al-Khairy, K., Carson, G., Luke, T. C., Hensley, L., Al-Dawood, A., Al-Qahtani, S., Modjarrad, K. & Sadat, M. & 3 others, Rohde, G., Leport, C. & Fowler, R., 19/11/2015, In: SpringerPlus. 2015, 4, 8 p., 709.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Bayesian adaptive dose-escalation procedures for binary and continuous responses utilizing a gain function

Yeung, W. Y., Whitehead, J. R., Reigner, B., Beyer, U., Diack, C. & Jaki, T. F., 11/2015, In: Pharmaceutical Statistics. 14, 6, p. 479-487 9 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of Telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy

Pushpakom, S. P., Taylor, C., Kolamunnage-Dona, R., Spowart, C., Vora, J., Garcıa-Finana, M., Kemp, G. J., Whitehead, J., Jaki, T., Khoo, S., Williamson, P. & Pirmohamed, M., 15/10/2015, In: BMJ Open. 5, 10, 13 p., e009566.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Partial stochastic dominance for the multivariate Gaussian distribution

Turner, A. & Whitehead, J., 08/2015, In: Statistics and Probability Letters. 103, p. 80-85 6 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Bayesian sample sizes for exploratory clinical trials comparing multiple experimental treatments with a control

Whitehead, J., Cleary, F. & Turner, A., 30/05/2015, In: Statistics in Medicine. 34, 12, p. 2048-2061 14 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosa

Beresford, M. W., Bracaglia, C., Caldas, A., Cimaz, R., Dehoorne, J., Dolezalova, P., Friswell, M., Jelusic, M., Marks, S. D., Martin, N., McMahon, A.-M., Peitz, J., van Royen-Kirkhof, A., Soylemezoglu, O., Brogan, P. & MYPAN Vasculitis Expert Group, 30/03/2015, In: PLoS ONE. 10, 3, 14 p., e0120981.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Bayesian methods for the design and interpretation of clinical trials in very rare diseases

Hampson, L., Whitehead, J., Eleftheriou, D. & Brogan, P., 30/10/2014, In: Statistics in Medicine. 33, 24, p. 4186-4201 16 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Designing exploratory cancer trials using change in tumour size as primary endpoint

Jaki, T., Andre, V., Su, T.-L. & Whitehead, J., 10/07/2013, In: Statistics in Medicine. 32, 15, p. 2544-2554 11 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review